Condensed Consolidated Statements of Cash Flows - USD ($) $ in Millions	3 Months Ended
	Sep. 30, 2025	Sep. 30, 2024
Cash flows from operating activities:
Net earnings/(loss)	$ 454	$ 417
Adjustments to reconcile net earnings to net cash provided by/(used in) operating activities:
Depreciation and amortization	233	182
Gain (Loss) on Sale of Investments	5	1
Impairments and (gain)/loss on disposal of assets, net	2	(1)
Share-based compensation	93	30
Provision for bad debts	13	16
Change in operating assets and liabilities, net of effects from acquisitions and divestitures:
(Increase)/decrease in trade receivables	(539)	288
Increase in inventories	(736)	(678)
Increase/(decrease) in accounts payable	2,147	(1,394)
Other accrued liabilities and operating items, net	(699)	(508)
Net cash provided by/(used in) operating activities	973	(1,647)
Cash flows from investing activities:
Additions to property and equipment	(108)	(90)
Payments to Acquire Businesses, Net of Cash Acquired	(41)	0
Increase (decrease) in other investing items, net	7	2
Net cash used in investing activities	(142)	(88)
Cash flows from financing activities:
Proceeds from Debt, Net of Issuance Costs	989	0
Reduction of long-term obligations	(512)	(9)
Payments to Noncontrolling Interests	3	0
Net tax withholding from share-based compensation	(80)	(28)
Dividends on common shares	(129)	(128)
Purchase of treasury shares	(375)	(375)
Net cash used in financing activities	(110)	(540)
Effect of exchange rates changes on cash and equivalents	(2)	9
Net increase/(decrease) in cash and equivalents	719	(2,266)
Cash and equivalents at beginning of period	3,874	5,133
Cash and equivalents at end of period	$ 4,593	$ 2,867